ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!Embecta Corp. (EMBC) stock declined over -3.10%, trading at $12.82 on NASDAQ, down from the previous close of $13.23. The stock opened at $12.99, fluctuating between $12.69 and $13.12 in the recent session.
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
Employees | 2100 |
Beta | 1.21 |
Sales or Revenue | $1.12B |
5Y Sales Change% | 0.006% |
Fiscal Year Ends | September |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com